SHO GRANT: Open Payments
NPI 1245785732 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 15 payments from 11 companies in 2025. Trend: 2023 $1,520 · 2024 $680 · 2025 $596
Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $148 |
| Merck Sharp & Dohme LLC | 1 | $108 |
| Telix Pharmaceuticals | 1 | $84 |
| TOLMAR, INC. | 3 | $69 |
| Antares Pharma, Inc. | 2 | $37 |
| DENTSPLY IH AB | 1 | $34 |
| ABBVIE INC. | 2 | $30 |
| COLOPLAST CORP | 1 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: ERLEADA, KEYTRUDA, ILLUCCIX, JATENZO, XYOSTED, LOFRIC, LUPRON DEPOT, Luja Coude.
Industry payments across AZ — which companies pay providers there.
